ASLAN Pharmaceuticals announced the appointment of Dr. Lawrence Eichenfield, MD, FAAD, as chair of its Scientific Advisory Board, comprising experts in dermatology and allergic disease from the United States, Canada, Europe, and Asia. Dr. Eric Simpson, MD, MCR, was also appointed as a board member. Dr. Lawrence Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children's Hospital-San Diego, Distinguished Professor of Dermatology and Pediatrics and Vice Chair of the Department of Dermatology at University of California San Diego School of Medicine. Dr. Eichenfield has served as lead author and co-chair of the committee for the American Academy of Dermatology Guidelines for Atopic Dermatitis? and sits on the editorial boards of multiple other journals and periodicals. In addition to his extensive clinical experience, he has authored over 400 publications on inflammatory skin disease. Dr. Eric Simpson is a Medical Dermatology Professor and the Director of Clinical Research at the Oregon Health and Science University Clinical Research Centre. He is Chair of the National Eczema Association (NEA) Research Advisory Committee and a member of the NEA Scientific and Medical Advisory Council and has authored over 200 publications on inflammatory skin disease.